Sexton Biotechnologies Raises $5M in Funding

healthcareSexton Biotechnologies, an Indianapolis-based biotechnology company, raised $5m in growth funding.

Backers included:
– BioLife Solutions (NASDAQ:BLFS) a developer and supplier of cell and gene therapy bioproduction tools,
– Casdin Capital,
– BioCrossroads, and
– Cook Regentec.

The company intents to use the funds to expand its ongoing research and product development and scale commercialization of its tools.

Led by Sean Werner, president, Sexton Biotechnologies is advancing a portfolio of container closure and media supplementation tools for cell and gene therapy bioproduction. Its portfolio includes the CellSeal platform of cryo-storage tools and fill/finish systems and human platelet lysate growth supplements.

Sexton, is comprised of a 17-person team from Cook Regentec, where the company was incubated, who developed and commercialized the products since 2015.
The company will lease production and office space inside Cook Regentec’s facility located in the 16 Tech Innovation District through 2024, maintaining continuous operations in the existing manufacturing facilities.




Join the discussion